ALKYLTRANSFERASE INHIBITORS FOR CANCER CHEMOTHERAPY

Project: Research project

StatusFinished
Effective start/end date8/1/964/30/12

Funding

  • National Institutes of Health: $274,109.00
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health: $202,458.00
  • National Institutes of Health: $179,262.00
  • National Institutes of Health: $239,567.00
  • National Institutes of Health: $274,022.00
  • National Institutes of Health: $239,649.00
  • National Institutes of Health: $250,931.00
  • National Institutes of Health: $196,313.00
  • National Institutes of Health: $250,931.00
  • National Institutes of Health: $239,729.00
  • National Institutes of Health: $258,426.00

Fingerprint

Alkyl and Aryl Transferases
Drug Therapy
Alkylating Agents
Neoplasms
Carmustine
Proteins
Oligodeoxyribonucleotides
Clinical Trials
Therapeutics
Folic Acid
temozolomide
Organized Financing
Prodrugs
Therapeutic Uses
Mutant Proteins
Heterografts
Nude Mice
Point Mutation
Genetic Therapy
Acids